ASC-US
Clinical trials for ASC-US explained in plain language.
Never miss a new study
Get alerted when new ASC-US trials appear
Sign up with your email to follow new studies for ASC-US, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaginal suppository aims to clear HPV and prevent cervical cancer
Disease control Recruiting nowThis study tests an experimental vaginal suppository called Dysplasix in women with high-risk HPV and mild cervical cell changes (ASC-US or LSIL). The goal is to see if the treatment can clear the virus and reverse the abnormal cells. Forty-five women will receive either the acti…
Matched conditions: ASC-US
Phase: PHASE2 • Sponsor: Amplexd Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 03:57 UTC
-
New vaccine combo aims to tackle persistent HPV infection
Disease control Recruiting nowThis early-stage trial tests whether two vaccines, given as a shot, are safe for people with a long-lasting HPV16 infection that has caused mild cervical cell changes. About 30 adults will receive the vaccines to find the best dose and check for side effects. The goal is to help …
Matched conditions: ASC-US
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 17, 2026 03:57 UTC